How to Buy Singular Genomics Systems Stock
Singular Genomics Systems Inc
Singular Genomics Systems, Inc. , a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine.
Singular Genomics Systems stock last closed at $0.40, up 0.75% from the previous day, and has decreased 60.39% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.49 percentage points. Singular Genomics Systems stock is currently +30.32% from its 52-week low of $0.31, and -66.61% from its 52-week high of $1.21.
As of Apr 26, 2024, there are 73.93M OMIC shares outstanding. The market capitalization of OMIC is $29.87M. In the last 24 hours, 105,987 OMIC shares were traded.
How to Buy Singular Genomics Systems Stock
Not sure how to invest in Singular Genomics Systems stock? Here's how.
- Decide where to buy Singular Genomics Systems stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Singular Genomics Systems stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Pick your payment method and add your info.
- Research Singular Genomics Systems stock: The Singular Genomics Systems ticker symbol is OMIC. Is Singular Genomics Systems stock a good investment? Should you buy shares of OMIC? How do OMIC's underlying business fundamentals look? Do top analysts think Singular Genomics Systems is a good buy? Why has OMIC's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if OMIC is a good stock to buy).
- Execute your OMIC buy order: Decide if you will purchase OMIC shares at the current market price or use a limit order to purchase OMIC shares at a given price.
- Get updates on your investment in OMIC: Create a watchlist to key updates about your investment in Singular Genomics Systems shares.
Step 1: Decide where to buy Singular Genomics Systems stock
You will need an online brokerage account in order to access the NASDAQ market and buy OMIC shares.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Technology to Energy, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you can buy OMIC stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have opened your account on app for stock, your next step is to transfer the money for your investment:
Check out the walkthrough below to see the process of depositing money into your new brokerage account.
Step 4: Research Singular Genomics Systems stock
After you have figured out the best place to buy Singular Genomics Systems stock, it's critical to research their stock before you buy, so you truly understand the risk and upside.
Singular Genomics Systems Metrics
Fundamentals of Singular Genomics Systems
WallStreetZen was designed to help everyday investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on OMIC's stock page.
Is OMIC stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge OMIC's true value.
Using relative valuations ratios:
- OMIC could be undervalued based on its P/B ratio of 0.17x, relative to Medical Instruments & Supplies industry P/B ratio of 3.53x
You can do additional valuation analysis on OMIC's stock here.
OMIC Financial Health Overview
Pros:
- There are more short-term assets than short-term liabilities on the OMIC balance sheet.
- OMIC has cash burn of 74617000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the OMIC balance sheet.
- OMIC has $174.54M in cash and short term investments. This is sufficient to cover its annual cash burn of $74.62M.
Cons:
- OMIC profit margin has gone up by 86.22 percentage points in the past year, but the company is still unprofitable.
- OMIC has a relatively high debt to equity ratio of 0.48.
Is OMIC stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 2 Equities analysts who give ratings on OMIC, the consensus analyst rating on OMIC is a Hold
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Singular Genomics Systems stock forecast page.
Metrics for Advanced OMIC Traders
How is OMIC performing as a company?
Last year, OMIC revenue was $2.91M. Over the last 1 years, OMIC's revenue has gone up by 280.52% per year. This was faster than the Medical Instruments & Supplies industry average of 9.46%.
You can analyze OMIC's earnings and revenue performance here.
Who is buying/selling OMIC?
Over the last 12 months, insiders at OMIC have sold more shares than they have bought.
Andrew Spaventa, Chief Executive Officer of OMIC, was the latest OMIC insider to buy. They bought $31,725.00 worth of OMIC shares on Nov 17, 2023.
Learn more about who owns OMIC shares here.
Does OMIC stock generate passive income?
No, Singular Genomics Systems doesn't provide an income stream by paying out dividends.
What others are saying about OMIC
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your OMIC buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a given price, place a limit order.
Press the Open button and eToro will place the order.
If you require more help with buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your investment in OMIC
Now that you own some OMIC shares, you'll want to stay up-to-date on your investment.
Create a watchlist to track the most important metrics related to your OMIC stock.
OMIC Feed
How to Buy Stock in Singular Genomics Systems
To summarize, here are the 6 steps you need to take to buy Singular Genomics Systems stock right now:
- Decide where to buy Singular Genomics Systems stock
- Sign up for your brokerage account
- Put funds into your brokerage account
- Research Singular Genomics Systems stock
- Execute your OMIC buy order
- Get updates on your investment in OMIC
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your new investment in Singular Genomics Systems, click the button below.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.